Active Shortage Injection Cardiovascular
Conivaptan Hydrochloride Inj · 1,642 days since initial FDA posting
FDA lists Conivaptan Hydrochloride Inj as Active Shortage (Cumberland Pharmaceuticals Inc.).
Availability on file: Unavailable
Conivaptan Hydrochloride Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Conivaptan Hydrochloride Injection
- Manufacturer
- Cumberland Pharmaceuticals Inc.
- Dosage Form
- Injection
- Presentation
- Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
- Package NDC
- 66220-160-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Mar 14, 2022
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.